Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 12.10.2020 | EN | Official Journal of the European Union | C 339/20 |

---

Judgment of the General Court of 8 July 2020 — Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben.)

(Case T-697/19) [(1)](#ntr1-C_2020339EN.01002001-E0001)

(EU trade mark - Application for EU word mark Weniger Migräne. Mehr vom Leben. - Absolute ground for refusal - No distinctive character - Article 7(1)(b) of Regulation (EU) 2017/1001)

(2020/C 339/25)

Language of the case: English

Parties

Applicant: Teva Pharmaceutical Industries Ltd (Petah Tikva, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)

Defendant: European Union Intellectual Property Office (represented by: L. Rampini and V. Ruzek, acting as Agents)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 (Case R 779/2019-5), relating to an application for registration of the word sign Weniger Migräne. Mehr vom Leben. as an EU trade mark.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Teva Pharmaceutical Industries Ltd to pay the costs. |

---

---

[Top](#document1)